학술논문
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients with COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load
Document Type
Article
Author
Dougan, M.; Azizad, M.; Mocherla, B.; Gottlieb, R.L.; Chen, P.; Hebert, C.; Perry, R.; Boscia, J.; Heller, B.; Morris, J.; Crystal, C.; Igbinadolor, A.; Huhn, G.; Cardona, J.; Shawa, I.; Kumar, P.; Blomkalns, A.; Adams, A.C.; Van Naarden, J.; Custer, K.L.; Knorr, J.; Oakley, G.; Schade, A.E.; Holzer, T.R.; Ebert, P.J.; Higgs, R.E.; Sabo, J.; Patel, D.R.; Dabora, M.C.; Williams, M.; Klekotka, P.; Shen, L.; Skovronsky, D.M.; Nirula, A.
Source
In: Clinical Infectious Diseases . (Clinical Infectious Diseases, 1 July 2022, 75(1):E440-E449)
Subject
Language
English
ISSN
15376591
10584838
10584838